当前位置: 首页 > 期刊 > 《特别健康.下半月》 > 2019年第7期
编号:13368620
普罗帕酮治疗小儿川崎病合并心律失常的疗效
http://www.100md.com 2019年7月1日 《特别健康·下半月》 2019年第7期
     【摘要】目的:探讨普罗帕酮治疗小儿川崎病合并心律失常的临床价值。方法:选取60例小儿川崎病合并心律失常为研究对象,随机分为对照组和实验组,分别采用美托洛尔及普罗帕酮治疗,比较两组患儿的治疗效果。结果:研究组心功能优于对照组(P<0.05)。结论:普罗帕酮能够改善小儿川崎病合并心律失常的心功能。

    【关键词】普罗帕酮;小儿;川崎病;心律失常

    [Abstract]Objective:To investigate the clinical value of propafenone in the treatment of children with Kawasaki disease complicated with arrhythmia.Methods:Sixty children with Kawasaki disease and arrhythmia were enrolled in the study. They were randomly divided into control group and experimental group. Metoprolol and propafenone were used to compare the therapeutic effects of the two groups.Results:The heart function of the study group was better than that of the control group (P<0.05).Conclusion:Propafenone can improve the cardiac function of children with Kawasaki disease and arrhythmia.

    【中图分类号】R766.1【文献标识码】A 【文章编号】2095-6851(2019)07-023-01

    小儿川崎病合并心律失常是一种十分危险的疾病 ......

您现在查看是摘要页,全文长 3753 字符